HELX US · ETF FactsheetFranklin Genomic Advancements ETF
Generated by Nukoud (nukoud.com) for informational purposes only — not investment advice, a recommendation, or an offer to buy or sell any security. Data is sourced from third-party providers and may be delayed or inaccurate. Past performance is not indicative of future results.
Franklin Genomic Advancements ETF
Exchange-Traded FundTechnical indicators
End of dayMoving averages
- 20-day SMA
- 43.2092 USD-2.35%Bearish
- 50-day SMA
- 42.9022 USD-1.65%Bearish
- 100-day SMA
- 41.6747 USD+1.25%Bullish
- 200-day SMA
- 37.8664 USD+11.43%Bullish
- 12-day EMA
- 43.1660 USD-2.25%Bearish
- 26-day EMA
- 43.1731 USD-2.27%Bearish
Oscillators
Sign in for the oscillators
RSI, MACD, Bollinger position and volatility for this fund — plus signal changes across every listing Nukoud tracks. A free account covers it.
Checking your session…Range & bands
Calculated from end-of-day closing prices. They describe how this fund has already traded, not what it will do next, and are information only — not advice.
About this fund
Franklin Genomic Advancements ETF (HELX) is a Thematic and Technology ETF managed by Franklin Advisers, Inc., listed on Cboe BZX U.S. Equities Exchange, quoted in USD. It charges a 0.50% net expense ratio and holds $34.82M in assets as of Nov 10, 2026. The fund launched on Feb 25, 2020.
- Benchmark
- Russell 3000Total return, USD
- Distribution
- Annually
- AUM
- $34.82M
- Expense Ratio
- 0.50%
- Yield (12-mo)
- —
- Morningstar Rating
- Benchmark
- Russell 3000
- 52-Week Range
- Avg Daily Vol
- 5.7K
- Inception
- Feb 25, 2020
Risk metrics
vs benchmark Russell 3000 · Total return, USD
3-year risk statistics are not currently available for this fund.
Risk statistics are 3-year, month-end-based.
Trailing returns
As of Nov 10, 2026Calendar-year returns
Morningstar daily closesTrading & liquidity
as of Nov 6, 2026
Average daily share volume over each trailing window. Spread is the average bid-ask spread as a percentage of price — lower means cheaper to trade.
Top 10 holdings
Source: MorningstarFees & expenses
Distributions
Recent payments per share (USD)
Classification
- Category
- Equity – Sector
- Asset class
- Equity
- Strategy
- Active
- Themes
- Genomics
- Sector
- Health Care
- Issuer
- Franklin Advisers, Inc.
- Branding
- Franklin Templeton
Similar ETFs
Funds sharing the same category or exposures.
- ARKGUS$1.97B0.750%+59.72%
ARK Genomic Revolution ETF
Same category · Same sector · genomics
- GNOMUS$105.76M0.500%+43.65%
Global X Genomics & Biotechnology ETF
Same category · Same sector · genomics
- XLVUS$50.35B0.080%+23.52%
State Street® Health Care Select Sector SPDR® ETF
Same category · Same sector
- IBBUS$11.34B0.440%+28.80%
iShares Biotechnology ETF
Same category · Same sector
- VGTUS$167.05B0.090%+17.70%
Vanguard Information Technology Index Fund
Same group
- XLKUS$114.21B0.080%+17.74%
State Street® Technology Select Sector SPDR® ETF
Same group
Frequently asked questions
- What is HELX's expense ratio?
- Franklin Genomic Advancements ETF charges a net expense ratio of 0.500%.
- How large is Franklin Genomic Advancements ETF?
- HELX holds $34.82M in assets under management.
- What index does HELX track?
- Franklin Genomic Advancements ETF tracks Russell 3000 as its primary benchmark.
- When did HELX launch?
- Franklin Genomic Advancements ETF launched on February 25, 2020.
- What currency does HELX trade in?
- HELX trades in USD on Cboe BZX U.S. Equities Exchange.
Fund information
- Ticker
- HELX
- Performance ID
- 0P0001ILBD
- Inception
- Feb 25, 2020
- Domicile
- USA
- Base currency
- USD
- Listing currency
- USD
- AUM
- $34.82M
- Firm AUM
- $1.80T
- Avg daily volume (3M)
- 5.7K
Charting by TradingView.
